|
|
|
|
|
 |
|
|
| Dear awha hawhwa, |
|
Since the start of the financing round for DiaMonTech AG, momentum has been unbroken. The investment amount now stands at over 7.4 million euros – impressive proof of the strong confidence in DiaMonTech's vision and technology.
In addition to numerous Companists, renowned co-investors such as Samsung are also participating in the round. Due to high demand, only a few company shares are still available. |
|
|
|
|
|
|
|
|
|
|
|
| INVESTMENT-HIGHLIGHTS |
|
|
|
|
| • |
|
Branche: DeepTech Healthcare |
|
|
| • |
|
Co-investment: with Samsung (€1.5 million) and Family Office (€1 million). |
|
|
| • |
|
Unique technology: Patented laser technology enables non-invasive glucose measurement without blood sampling. |
|
|
| • |
|
Award-winning: Deep Tech Berlin Award and i-Health Award. |
|
|
| • |
|
IP portfolio: Over 100 patents and patent applications. |
|
|
| • |
|
Attractive exit scenario: High valuation potential – successful CGM providers achieve valuations in the billions. |
|
|
| • |
|
International investor group: including Samsung (South Korea), Medtronic (Ireland), Unorthdox Ventures (USA), Macnica Ventures (Japan), Bioventure Health Care (Dubai), IBB (Germany), Disrupt Impact Fund (Thailand). |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Download our app |
|
| The Companisto app makes investing even easier |
|
|
|
|
|
|
|
|
|
|
|
| Companisto GmbH |
|
Köpenicker Str. 154, 10997 Berlin
Managing Director: Tamo Zwinge, LL. M. and David Rhotert
Amtsgericht: Berlin Charlottenburg HRB 132811 B
VAT-ID: DE 276 014 929
Phone: +49 30 330 837 49
Email: service@companisto.com |
|
|
|
|
|
|
|
|
| You receive this newsletter because you have subscribed to it. You can unsubscribe at any time via the unsubscribe link. |
|
| The acquisition of the offered securities and investments is associated with considerable risks and can lead to the complete loss of the invested assets. The expected yield is not guaranteed and may be lower. Whether it is a security or an asset investment can be seen in the description of the investment opportunity. |
|
|
|
|
